Clearside Biomedical Inc (CLSD)
0.8723
-0.06
(-6.20%)
USD |
NASDAQ |
Dec 20, 16:00
0.865
-0.01
(-0.84%)
After-Hours: 20:00
Clearside Biomedical Shareholders Equity (Quarterly): -34.79M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Viking Therapeutics Inc | 911.45M |
| Atara Biotherapeutics Inc | -90.54M |
| Corvus Pharmaceuticals Inc | 12.41M |
| Crinetics Pharmaceuticals Inc | 832.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.16M |
| Total Liabilities (Quarterly) | 63.95M |
| Current Ratio | 4.490 |